SAR evolution towards potent C-terminal carboxamide peptide inhibitors of Zika virus NS2B-NS3 protease
Stefania Colarusso, Federica Ferrigno, Simona Ponzi et al. · Bioorganic & Medicinal Chemistry · 2022
Cited by 11 works. doi:10.1016/j.bmc.2022.116631
Authors
- Stefania Colarusso
- Federica Ferrigno
- Simona Ponzi
- Francesca Pavone
- Immacolata Conte
- Luigi Abate
- Elisa Beghetto
- Antonino Missineo
- Jérôme Amaudrut
- Alberto Bresciani
- Giacomo Paonessa
- Licia Tomei
- Christian Montalbetti
- Elisabetta Bianchi
- Carlo Toniatti
- Jesus M. Ontoria
References
- Zika Virus (I). Isolations and serological specificity
- Zika Virus Infection as a Cause of Congenital Brain Abnormalities and Guillain–Barré Syndrome: Systematic Review
- Crystal structure of Zika virus NS2B-NS3 protease in complex with a boronate inhibitor
- Biochemistry and Molecular Biology of Flaviviruses
- Structure of the NS2B-NS3 protease from Zika virus after self-cleavage
- Peptide–Boronic Acid Inhibitors of Flaviviral Proteases: Medicinal Chemistry and Structural Biology
- Discovery of Nanomolar Dengue and West Nile Virus Protease Inhibitors Containing a 4-Benzyloxyphenylglycine Residue
- Phenylalanine and Phenylglycine Analogues as Arginine Mimetics in Dengue Protease Inhibitors
- Extended substrate specificity and first potent irreversible inhibitor/activity-based probe design for Zika virus NS2B-NS3 protease
- Phenylglycine racemization in Fmoc-based solid-phase peptide synthesis: Stereochemical stability is achieved by choice of reaction conditions